Founded in 2023, the Gulbenkian Institute for Molecular Medicine (GIMM) is a pioneering Portuguese private research foundation with an ambitious vision for fundamental scientific exploration and its profound impact on global health and well-being.

GIMM is dedicated to unraveling the fundamental mysteries of life and aims to be at the forefront of transdisciplinary research. From the beginning, GIMM has strived for scientific excellence and societal impact, driving the future of molecular medicine for a healthier world.

GIMM was born from the merger of two leading research institutes: Instituto de Medicina Molecular João Lobo Antunes (iMM) and Instituto Gulbenkian de Ciência (IGC). This strategic union combines both institutes’ strengths, expertise and resources, enhancing our research capabilities and fostering synergies to address complex scientific challenges.